Experimental design in reversed-phase high-performance liquid chromatographic analysis of imatinib mesylate and its impurity

Guidance for robustness/ruggedness tests in method validation

Yvan Vander Heyden, Arend Nijhuis, J. Smeyers–Verbeke et al. · Journal of Pharmaceutical and Biomedical Analysis · 2001 · 630 citations

Pharmacy, Pharmaceutical Analysis, Method Validation +9

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec™) and its main metabolite (CGP 74588) in human plasma using liquid chromatography–tandem mass spectrometry

Ray Bakhtiar, Jack J. Lohne, Lourdes Ramos et al. · Journal of Chromatography B · 2002 · 143 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Experimental design I. Screening

Pedro Araujo, Richard G. Brereton · TrAC Trends in Analytical Chemistry · 1996 · 113 citations

Public Health, Biostatistics, Experimental Design +9

Design of experiment and data analysis by JMP® (SAS institute) in analytical method validation

June Liu, Feiyan Ren, Ngozi Okafo · Journal of Pharmaceutical and Biomedical Analysis · 2000 · 80 citations

Pharmacy, Biostatistics, Experimental Design +10

Full and fractionated experimental designs for robustness testing in the high-performance liquid chromatographic analysis of codeine phosphate, pseudoephedrine hydrochloride and chlorpheniramine maleate in a pharmaceutical preparation

Ruby Ragonese, M. Mulholland, John R. Kalman · Journal of Chromatography A · 2000 · 77 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +16